(DHI) DR Horton - Ratings and Ratios
SingleFamily Homes, Attached Homes, Mortgage Financing, Rental Properties
DHI EPS (Earnings per Share)
DHI Revenue
Description: DHI DR Horton
D.R. Horton, Inc. is a leading homebuilding company operating in multiple regions across the United States, with a presence in 125 markets across 36 states. The companys diversified product offerings include single-family detached homes, attached homes, and multi-family properties, catering to a wide range of homebuyers. Additionally, D.R. Horton provides mortgage financing services, title insurance, and closing services, creating a comprehensive ecosystem for its customers.
From a financial perspective, D.R. Hortons market capitalization stands at approximately $41.8 billion, indicating a significant presence in the homebuilding industry. The companys price-to-earnings ratio is around 10.32, suggesting a relatively attractive valuation compared to its earnings. Furthermore, the forward P/E ratio is 11.17, indicating a slight increase in expected earnings growth. The return on equity (RoE) is 17.21%, demonstrating a respectable level of profitability.
To further analyze D.R. Hortons performance, key performance indicators (KPIs) such as revenue growth, gross margin, and inventory turnover can be examined. The companys revenue growth is influenced by factors like housing demand, land acquisition, and construction activity. Gross margin, which is a critical metric in the homebuilding industry, is affected by factors like land costs, construction costs, and selling prices. Additionally, metrics like homebuilding gross margin, SG&A as a percentage of revenue, and land inventory turnover can provide insights into the companys operational efficiency.
Other relevant KPIs for D.R. Horton include its home sales data, including average sales price and sales volume, which can indicate the companys market share and pricing power. The companys land holdings and pipeline of new projects are also crucial in assessing its future growth prospects. By examining these KPIs, a more comprehensive understanding of D.R. Hortons financial health, operational efficiency, and growth prospects can be obtained.
DHI Stock Overview
| Market Cap in USD | 49,936m |
| Sub-Industry | Homebuilding |
| IPO / Inception | 1992-06-05 |
DHI Stock Ratings
| Growth Rating | 28.3% |
| Fundamental | 65.5% |
| Dividend Rating | 59.9% |
| Return 12m vs S&P 500 | -21.6% |
| Analyst Rating | 3.62 of 5 |
DHI Dividends
| Dividend Yield 12m | 1.04% |
| Yield on Cost 5y | 2.36% |
| Annual Growth 5y | 12.39% |
| Payout Consistency | 83.1% |
| Payout Ratio | 12.8% |
DHI Growth Ratios
| Growth Correlation 3m | 97% |
| Growth Correlation 12m | -57.1% |
| Growth Correlation 5y | 82.2% |
| CAGR 5y | 20.15% |
| CAGR/Max DD 5y | 0.45 |
| Sharpe Ratio 12m | -0.28 |
| Alpha | -15.61 |
| Beta | 0.217 |
| Volatility | 32.77% |
| Current Volume | 2337.7k |
| Average Volume 20d | 3640.8k |
| Stop Loss | 163.3 (-3.6%) |
| Signal | 0.00 |
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (3.96b TTM) > 0 and > 6% of Revenue (6% = 2.07b TTM) |
| FCFTA 0.08 (>2.0%) and ΔFCFTA 1.59pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 95.24% (prev 85.01%; Δ 10.23pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 2.91b <= Net Income 3.96b (YES >=105%, WARN >=100%) |
| Net Debt (4.69b) to EBITDA (5.34b) ratio: 0.88 <= 3.0 (WARN <= 3.5) |
| Current Ratio 16.41 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (304.9m) change vs 12m ago -7.63% (target <= -2.0% for YES) |
| Gross Margin 24.80% (prev 26.28%; Δ -1.49pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 96.65% (prev 106.1%; Δ -9.47pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 75.79 (EBITDA TTM 5.34b / Interest Expense TTM 69.2m) >= 6 (WARN >= 3) |
Altman Z'' 12.32
| (A) 0.90 = (Total Current Assets 35.07b - Total Current Liabilities 2.14b) / Total Assets 36.40b |
| (B) 0.83 = Retained Earnings (Balance) 30.25b / Total Assets 36.40b |
| warn (B) unusual magnitude: 0.83 — check mapping/units |
| (C) 0.15 = EBIT TTM 5.24b / Avg Total Assets 35.77b |
| (D) 2.56 = Book Value of Equity 30.26b / Total Liabilities 11.80b |
| Total Rating: 12.32 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 65.52
| 1. Piotroski 5.0pt = 0.0 |
| 2. FCF Yield 4.97% = 2.49 |
| 3. FCF Margin 8.09% = 2.02 |
| 4. Debt/Equity 0.37 = 2.43 |
| 5. Debt/Ebitda 1.68 = 0.63 |
| 6. ROIC - WACC 7.18% = 8.98 |
| 7. RoE 16.07% = 1.34 |
| 8. Rev. Trend -0.84% = -0.04 |
| 9. Rev. CAGR -1.58% = -0.26 |
| 10. EPS Trend -26.34% = -0.66 |
| 11. EPS CAGR -11.25% = -1.41 |
What is the price of DHI shares?
Over the past week, the price has changed by -0.70%, over one month by +15.32%, over three months by +43.67% and over the past year by -8.28%.
Is DR Horton a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of DHI is around 176.51 USD . This means that DHI is currently overvalued and has a potential downside of 4.15%.
Is DHI a buy, sell or hold?
- Strong Buy: 6
- Buy: 3
- Hold: 10
- Sell: 2
- Strong Sell: 0
What are the forecasts/targets for the DHI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 158.9 | -6.2% |
| Analysts Target Price | 158.9 | -6.2% |
| ValueRay Target Price | 192.1 | 13.3% |
Last update: 2025-08-29 04:36
DHI Fundamental Data Overview
CCE Cash And Equivalents = 2.61b USD (last quarter)
P/E Trailing = 13.4538
P/E Forward = 13.2802
P/S = 1.4443
P/B = 2.0761
P/EG = 1.7813
Beta = 1.343
Revenue TTM = 34.58b USD
EBIT TTM = 5.24b USD
EBITDA TTM = 5.34b USD
Long Term Debt = 7.25b USD (from longTermDebt, last quarter)
Short Term Debt = 1.70b USD (from shortTermDebt, last quarter)
Debt = 8.95b USD (Calculated: Short Term 1.70b + Long Term 7.25b)
Net Debt = 4.69b USD (from netDebt column, last quarter)
Enterprise Value = 56.27b USD (49.94b + Debt 8.95b - CCE 2.61b)
Interest Coverage Ratio = 75.79 (Ebit TTM 5.24b / Interest Expense TTM 69.2m)
FCF Yield = 4.97% (FCF TTM 2.80b / Enterprise Value 56.27b)
FCF Margin = 8.09% (FCF TTM 2.80b / Revenue TTM 34.58b)
Net Margin = 11.46% (Net Income TTM 3.96b / Revenue TTM 34.58b)
Gross Margin = 24.80% ((Revenue TTM 34.58b - Cost of Revenue TTM 26.00b) / Revenue TTM)
Tobins Q-Ratio = 1.86 (Enterprise Value 56.27b / Book Value Of Equity 30.26b)
Interest Expense / Debt = 0.34% (Interest Expense 30.3m / Debt 8.95b)
Taxrate = 23.53% (from yearly Income Tax Expense: 1.48b / 6.28b)
NOPAT = 4.01b (EBIT 5.24b * (1 - 23.53%))
Current Ratio = 16.41 (Total Current Assets 35.07b / Total Current Liabilities 2.14b)
Debt / Equity = 0.37 (Debt 8.95b / last Quarter total Stockholder Equity 24.05b)
Debt / EBITDA = 1.68 (Net Debt 4.69b / EBITDA 5.34b)
Debt / FCF = 3.20 (Debt 8.95b / FCF TTM 2.80b)
Total Stockholder Equity = 24.66b (last 4 quarters mean)
RoA = 10.89% (Net Income 3.96b, Total Assets 36.40b )
RoE = 16.07% (Net Income TTM 3.96b / Total Stockholder Equity 24.66b)
RoCE = 16.44% (Ebit 5.24b / (Equity 24.66b + L.T.Debt 7.25b))
RoIC = 13.00% (NOPAT 4.01b / Invested Capital 30.85b)
WACC = 5.81% (E(49.94b)/V(58.89b) * Re(6.81%)) + (D(8.95b)/V(58.89b) * Rd(0.34%) * (1-Tc(0.24)))
Shares Correlation 5-Years: -100.0 | Cagr: -4.07%
Discount Rate = 6.81% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 78.95% ; FCFE base≈2.54b ; Y1≈2.66b ; Y5≈3.09b
Fair Price DCF = 181.9 (DCF Value 54.22b / Shares Outstanding 298.1m; 5y FCF grow 5.06% → 3.0% )
Revenue Correlation: -0.84 | Revenue CAGR: -1.58%
Rev Growth-of-Growth: -13.26
EPS Correlation: -26.34 | EPS CAGR: -11.25%
EPS Growth-of-Growth: -18.36
Additional Sources for DHI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle